SLE (SYSTEMIC LUPUS)
Clinical trials for SLE (SYSTEMIC LUPUS) explained in plain language.
Never miss a new study
Get alerted when new SLE (SYSTEMIC LUPUS) trials appear
Sign up with your email to follow new studies for SLE (SYSTEMIC LUPUS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take on tough lupus cases
Disease control CompletedThis early-stage trial tested a new treatment for people with severe lupus that did not improve with standard medicines. Three patients received specially engineered immune cells (CAR T-cells) designed to target and calm the overactive immune system. The main goal was to check sa…
Matched conditions: SLE (SYSTEMIC LUPUS)
Phase: PHASE1 • Sponsor: Chulalongkorn University • Aim: Disease control
Last updated May 17, 2026 04:26 UTC
-
New drug NTR-1011 tested for safety in lupus and arthritis patients
Disease control CompletedThis early-stage study tested the safety of a new drug called NTR-1011 in 36 healthy adults and people with lupus or rheumatoid arthritis. The goal was to find a safe dose and see how the drug works in the body. It was a randomized, double-blind, placebo-controlled trial, meaning…
Matched conditions: SLE (SYSTEMIC LUPUS)
Phase: PHASE1 • Sponsor: Neutrolis • Aim: Disease control
Last updated May 07, 2026 18:42 UTC